Details of the Drug
General Information of Drug (ID: DM0BHCJ)
Drug Name |
Pyrrolidin-3-yl-acetic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
89203-64-5; 2-(pyrrolidin-3-yl)acetic acid; 3-PYRROLIDINEACETIC ACID; 3-Pyrrolidineaceticacid; Pyrrolidin-3-yl-acetic acid; 2-pyrrolidin-3-ylacetic Acid; pyrrolidin-3-ylacetic acid; CHEMBL351355; 2-(Pyrrolidin-3yl)acetic acid; Homo-beta-proline; ACMC-20liyx; ACMC-20mq1s; pyrrolidine-3-acetic acid; AC1N49FZ; SCHEMBL374930; CTK3E7957; OUENRUZPZZFMCA-UHFFFAOYSA-N; MolPort-001-729-044; KS-000003FH; BDBM50013224; 3-pyrrolidineacetic acid, AldrichCPR; 3-pyrrolidineacetic acid hydrochloride; AKOS005264421; MCULE-3887627276; RP19856
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 129.16 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -2.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||